Clinical trial

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With…

NCT00003751 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00003751
Title Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
Official title Phase II Study of Penicillamine and Reduction of Copper for Angiosuppressive Therapy of Adults With Newly Diagnosed Glioblastoma
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Brain and Central Nervous System Tumors
Intervention type Drug, Radiation
Interventions penicillamine, radiation therapy
Enrollment 40
Start date Mar 1, 1999
Primary completion Jun 1, 2004
Completion Jul 1, 2005
First posted Aug 18, 2004
Last update posted May 3, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies